发明授权
- 专利标题： Long acting formulation of biopharmaceutical
- 专利标题（中）： 长效配方的生物制药
-
申请号： US12422950申请日： 2009-04-13
-
公开(公告)号： US08247493B2公开(公告)日： 2012-08-21
- 发明人: Sei-Kwang Hahn , Hyun-Gu Kang , Sung-Ho Ryu , Jung-Kyu Park , Eun-Ju Oh
- 申请人： Sei-Kwang Hahn , Hyun-Gu Kang , Sung-Ho Ryu , Jung-Kyu Park , Eun-Ju Oh
- 申请人地址： KR Pohang KR Pohang-shi
- 专利权人： Postech Academy-Industry Foundation,Posco
- 当前专利权人： Postech Academy-Industry Foundation,Posco
- 当前专利权人地址： KR Pohang KR Pohang-shi
- 代理机构： JHK Law
- 代理商 Joseph Hyosuk Kim
- 主分类号： A61K47/48
- IPC分类号： A61K47/48
摘要：
The invention relates to a long-acting formulation of biopharmaceutical, more specifically an aptamer therapeutics. A branched PEGylated aptamer or a hyaluronic acid (HA) derivative of which degradation in vivo is regulated is linked by the bioconjugation with biopharmaceutical to produce the long-action formulation.
公开/授权文献
- US20110111477A9 LONG ACTING FORMULATION OF BIOPHARMACEUTICAL 公开/授权日：2011-05-12
信息查询
